Literature DB >> 25463070

Vascular proteoglycans and atherosclerosis: not over yet.

Lisa R Tannock1.   

Abstract

Entities:  

Keywords:  Atherosclerosis; Biglycan; Collagen; Proteoglycans

Mesh:

Substances:

Year:  2014        PMID: 25463070      PMCID: PMC4558617          DOI: 10.1016/j.atherosclerosis.2014.08.055

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  18 in total

1.  Decorin overexpression reduces atherosclerosis development in apolipoprotein E-deficient mice.

Authors:  Ayman Al Haj Zen; Giuseppina Caligiuri; Julie Sainz; Mathilde Lemitre; Corinne Demerens; Antoine Lafont
Journal:  Atherosclerosis       Date:  2005-09-23       Impact factor: 5.162

Review 2.  The response-to-retention hypothesis of early atherogenesis.

Authors:  K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

3.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

Authors:  A Hildebrand; M Romarís; L M Rasmussen; D Heinegård; D R Twardzik; W A Border; E Ruoslahti
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

4.  Identification of osteoglycin as a component of the vascular matrix. Differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques.

Authors:  C M Shanahan; N R Cary; J K Osbourn; P L Weissberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-11       Impact factor: 8.311

5.  Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration.

Authors:  Yutaka Nakashima; Hiroshi Fujii; Shinji Sumiyoshi; Thomas N Wight; Katsuo Sueishi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-15       Impact factor: 8.311

6.  Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins.

Authors:  K D O'Brien; K L Olin; C E Alpers; W Chiu; M Ferguson; K Hudkins; T N Wight; A Chait
Journal:  Circulation       Date:  1998-08-11       Impact factor: 29.690

7.  Increased atherosclerosis in mice with increased vascular biglycan content.

Authors:  Joel C Thompson; Tao Tang; Patricia G Wilson; Meghan H Yoder; Lisa R Tannock
Journal:  Atherosclerosis       Date:  2014-04-15       Impact factor: 5.162

Review 8.  The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly.

Authors:  Shoujun Chen; David E Birk
Journal:  FEBS J       Date:  2013-02-14       Impact factor: 5.542

Review 9.  Biological interplay between proteoglycans and their innate immune receptors in inflammation.

Authors:  Helena Frey; Nina Schroeder; Tina Manon-Jensen; Renato V Iozzo; Liliana Schaefer
Journal:  FEBS J       Date:  2013-02-21       Impact factor: 5.542

10.  Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development.

Authors:  Fei Huang; Joel C Thompson; Patricia G Wilson; Hnin H Aung; John C Rutledge; Lisa R Tannock
Journal:  J Lipid Res       Date:  2007-11-21       Impact factor: 5.922

View more
  2 in total

Review 1.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

2.  Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans.

Authors:  Mariola Olkowicz; Izabela Czyzynska-Cichon; Natalia Szupryczynska; Renata B Kostogrys; Zdzislaw Kochan; Janusz Debski; Michal Dadlez; Stefan Chlopicki; Ryszard T Smolenski
Journal:  J Transl Med       Date:  2021-01-06       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.